Longitude Capital

About Longitude Capital

Longitude Capital specializes in making venture growth investments in biotechnology and medical technology companies that seek to improve clinical outcomes, enhance quality of life and/or reduce system costs. We invest in both privately held and publicly traded life science companies through a variety of investment approaches. Since 2006, Longitude Capital has raised over $1.2 billion across three funds and demonstrated an ability to source, manage and exit attractive investments across multiple market cycles.



June 2018 - July 2018 Greenwich, CT
“I learned a lot about financial modeling that I had not had the opportunity to learn before”
See All